Adagen® (pegademase bovine) – PRODUCT INFORMATION

Overview | Product Information | Accredo Services | Contact Team

ADAGEN is indicated for enzyme replacement therapy for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency disease (SCID) who are not suitable candidates for or who have failed bone marrow transplantation.

For more information, please download the full prescribing information.

Adagen is a registered trademark of Enzon Pharmaceuticals, Inc.